12:00 AM
 | 
Mar 13, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Injectable collagenase enzyme regulatory update

BSTC received U.S. Patent No. 6,022,539 covering the use of its injectable collagenase enzyme...

Read the full 47 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >